Hutch News

Hutch News

Stories tagged 'Catherine Tangen'

Dr. James Dai receives $2.1M NCI grant for cancer biomarker research

Biostatistician plans to use funds to develop statistical models to further precision cancer prevention and treatment

Aug. 20, 2018 | By Colin Petersdorf / Fred Hutch News Service

Fred Hutch biostatistician Dr. James Dai recently was awarded a $2.1 million grant from the National Cancer Institute to develop new analytical methods for identifying genetic and epigenetic alterations that drive cancers. He hopes this work will facilitate the discovery of molecular cancer drivers — biomarkers — and the development of new preventive, diagnostic and prognostic techniques.

View story >


Matching up cancer risk with reality

New examination of prostate cancer data identifies ‘detection bias’ in prostate studies

Oct. 31, 2016 | By Diane Mapes / Fred Hutch News Service

A new Fred Hutch-led study suggests variation in prostate cancer biopsy patterns, i.e., who does and who doesn't get screened, may have colored our perception of risk for the disease.

View story >


Intermittent hormone therapy for prostate cancer inferior to continuous therapy

Cathy Tangen contributes to international study, finding on again-off again prostate cancer treatment has quality of life benefits, but continuous therapy improves overall survival

June 4, 2012

Many men with metastatic, hormone-sensitive prostate cancer live longer on continuous androgen-deprivation therapy (also known as hormone therapy) than on intermittent therapy, according to a 17-year study led by SWOG (formerly Southwest Oncology Group), a cancer research cooperative group.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.